Skip to main content
Caplight Logo









MicroQuin

MicroQuin

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.microquin.com/

Last Round

Grant

Feb 1, 2025

Company Overview

MicroQuin is a biotechnology company developing therapeutics that modulate the intracellular environment to treat cancer, neurodegenerative disorders, and viral infections.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Application

Keywords

small molecule drugsoncology therapeuticsdrug discoveryintracellular environment modulationpreclinical biotechsolid tumor treatmentAI drug discoverypharma partnershipsAI biotechneurodegenerative disease treatmentviral disease treatmentCongressionally Directed Medical Research ProgramsCDMRP

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MicroQuin Comparables

Compare MicroQuin with similar companies based on industry and business-model similarity.

MicroQuin comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EtiraRx
82%
Celloram Inc.
78%
Aprea Therapeutics
72%

MicroQuin Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 1, 2025
GrantOct 18, 2018
AcceleratorMay 23, 2018

MicroQuin Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 36% MoM.

  • Feb 1, 2025

    Received funding from Congressionally Directed Medical Research Programs.

MicroQuin Filings

Explore SEC and related filing metadata, where available.

MicroQuin filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MicroQuin's valuation, stock price, and market status.

Is MicroQuin a public or private company?

MicroQuin is a private company.

What is the current stock price of MicroQuin?

MicroQuin is a private company with no public stock price. No recent secondary market data is available.

How much is MicroQuin worth (valuation)?

Valuation information for MicroQuin is not publicly available.

Can I buy MicroQuin stock?

MicroQuin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MicroQuin's last funding round?

Funding round information for MicroQuin is not publicly available.

Who are the main investors in MicroQuin?

Investor information for MicroQuin is not publicly disclosed.

Will MicroQuin IPO soon?

No public IPO plans have been announced for MicroQuin.

How can I track MicroQuin secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MicroQuin's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range2
Year Founded2016
Last FundingFeb 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?